Prediction of therapeutic effect of chemotherapy for NSCLC using dual-input perfusion CT analysis: Comparison among bevacizumab treatment, two- agent platinum-based therapy without bevacizumab, and other non- bevacizumab treatment groups

Research output: Contribution to journalArticle

1 Citation (Scopus)

Fingerprint Dive into the research topics of 'Prediction of therapeutic effect of chemotherapy for NSCLC using dual-input perfusion CT analysis: Comparison among bevacizumab treatment, two- agent platinum-based therapy without bevacizumab, and other non- bevacizumab treatment groups'. Together they form a unique fingerprint.

Medicine & Life Sciences